Navigation Links
Teens Should Get Meningitis Booster Shot: CDC Panel
Date:10/27/2010

By Steven Reinberg
HealthDay Reporter

WEDNESDAY, Oct. 27 (HealthDay News) -- Teenagers should get a booster shot of the vaccine that protects against bacterial meningitis, a U.S. health advisory panel recommended Wednesday.

The panel made the recommendation because the vaccine appears not to last as long as previously thought.

In 2007, the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices recommended that the meningitis vaccine -- usually given to college freshman -- be offered to 11 and 12 year olds, the Associated Press reported. The vaccine was initially aimed at high school and college students because bacterial meningitis is more dangerous for teens and can spread easily in crowded settings, such as dorm rooms.

At that time the panel thought the vaccine would be effective for at least 10 years. But, information presented at the panel's meeting Wednesday showed the vaccine is effective for less than five years.

The panel then decided to recommend that teens should get a booster shot at 16.

Although the CDC is not bound by its advisory panels' recommendations, the agency usually adopts them. However, a U.S. Food and Drug Administration official, Norman Baylor, said more studies about the safety and effectiveness of a second dose of the vaccine are needed, the AP reported.

Some at the meeting wondered if it was even necessary to make such a decision. Cases of bacterial meningitis are at historic lows, and a survey of more than 200 colleges and universities -- representing more than 2 million students -- in the last academic year found 11 cases of bacterial meningitis and three deaths, the AP reported.

In a news release issued after the vote, the National Meningitis Association said it "supports [the] decision to maintain meningococcal immunization at age 11-12 and to add a booster dose to provide increased prevention of disease among adolescents throughout their high-risk years. This is a good public health decision that will protect our children from meningococcal disease."

Meningitis is an inflammation of the membranes that cover the brain and spinal cord, and is usually caused by a viral or bacterial infection. The disease can result in brain damage, hearing loss or learning disabilities, according to the CDC.

In January, the New England Journal of Medicine published a study that found that rates of pneumococcal meningitis have declined substantially since a vaccine was introduced in 2000.

The declines were seen not only in children given the vaccine but also in adults, suggesting a "herd immunity" effect, the study authors noted.

To assess the effect of the vaccine, researchers from several universities analyzed surveillance data from 1998 to 2005 in eight states. The number of cases of the disease dropped 30 percent in that time, but the effect on the very youngest and oldest was even more pronounced: Incidence decreased by 64 percent in those younger than 2 and by 54 percent in those older than 65.

More information

For more on meningitis, visit the U.S. Centers for Disease Control and Prevention.

SOURCES: Oct. 27, 2010, news release, National Meningitis Association, Atlanta; Associated Press


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Gastric Banding Most Effective for Obese Teens
2. Tired Teens Prone to Car Crashes
3. Teens Might Exercise More If They Think Its Fun
4. Are Latino teens sexual risk takers? Its complicated, researcher says
5. VIDEO from Medialink and Juice Products Association: Teens Who Drink Juice Have Healthier Diets, Eat More Whole Fruit
6. Program could help teens control asthma
7. Julian Krinsky Rolls Out Brand New Fitness Program for Busy Teens
8. Book explains how focus on strengths, not failures, helps teens succeed in school
9. Counteracting teens logo lust
10. Teens Take Risks Just for Kicks
11. Crack and cocaine use a significant HIV risk factor for teens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... its new partnership with the Home Care Association of America (HCAOA). This agreement ... Private Duty Accreditation services, as well as discounts on Accreditation University (AU) educational ...
(Date:4/28/2017)... ... , ... Beginning in 2017, Ridgecrest Herbals will be phasing out the homeopathic ... Extra Strength formula. To ensure that the effectiveness of Clear Lungs Extra Strength is ... , Removal of the homeopathic element , Adding their patented ...
(Date:4/28/2017)... ... April 28, 2017 , ... GlycoMark, Inc. ... GlycoMark test throughout the Northeast U.S. , GlycoMark is the only clinically ... GlycoMark test provides a clinically proven one- to two-week measure of hyperglycemic excursions, ...
(Date:4/28/2017)... Fairfax, VA (PRWEB) , ... April 28, 2017 , ... ... elected volunteer board members and officers for 2017-2018. The annual board election process has ... serving on a volunteer basis. , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, ...
(Date:4/28/2017)... ... , ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical ... Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord ... donate. , “Women’s Hospital at Renaissance has been a collection partner for the ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017 Global Prostate Cancer Therapeutics ... the prostate cancer therapeutics market analyzes the current ... prevalence of prostate cancer, launch of promising emerging ... of new drugs & therapeutic biological products, and ... to lesser side effects are some of the ...
(Date:4/19/2017)... DIEGO , April 19, 2017  Sorrento ... an antibody-centric, clinical-stage biopharmaceutical company developing new treatments ... announced the closing of its previously announced underwritten ... stock at a public offering price of $2.00 ... and estimated offering expenses payable by Sorrento.  The ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
Breaking Medicine Technology: